Skip to main content

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells

Include preview-only content
  1. Article

    Open Access

    Students’ guide to documentation in clinical trials

    In the wake of the coronavirus disease 2019 (COVID-19) pandemic, support in clinical trials by students of human medicine and related disciplines has become of even greater importance than in pre-pandemic time...

    Johannes Heck, Ann-Kathrin Rath, Katrin Wons in European Journal of Clinical Pharmacology (2022)

  2. Article

    Open Access

    Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

    We used the RNActive® technology platform (CureVac N.V., Tübingen, Germany) to prepare CVnCoV, a COVID-19 vaccine containing sequence-optimized mRNA coding for a stabilized form of SARS-CoV‑2 spike (S) protein...

    Peter G. Kremsner, Philipp Mann MD, Arne Kroidl in Wiener klinische Wochenschrift (2021)